Centro de Biologia Molecular Estrutural (CEBIME) and.
J Enzyme Inhib Med Chem. 2015 Apr;30(2):299-307. doi: 10.3109/14756366.2014.920839. Epub 2014 Jun 25.
Falcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many previous studies have identified FP-2 inhibitors; however, none has yet met the criteria for an antimalarial drug candidate. In this work, we assayed an in-house library of non-peptidic organic compounds, including (E)-chalcones, (E)-N'-benzylidene-benzohydrazides and alkyl-esters of gallic acid, and assessed the activity toward FP-2 and their mechanisms of inhibition. The (E)-chalcones 48, 54 and 66 showed the lowest IC50 values (8.5 ± 0.8 µM, 9.5 ± 0.2 µM and 4.9 ± 1.3 µM, respectively). The best inhibitor (compound 66) demonstrated non-competitive inhibition, and using mass spectrometry and fluorescence spectroscopy assays, we suggest a potential allosteric site for the interaction of this compound, located between the catalytic site and the hemoglobin binding arm in FP-2. We combined structural biology tools and mass spectrometry to characterize the inhibition mechanisms of novel compounds targeting FP-2.
疟原虫裂殖子蛋白 2(FP-2)是一种重要的半胱氨酸蛋白酶。许多先前的研究已经鉴定出 FP-2 抑制剂;然而,迄今为止,没有一种抑制剂符合抗疟药物候选物的标准。在这项工作中,我们对包括(E)-查耳酮、(E)-N'-苄叉苯甲酰肼和没食子酸烷基酯在内的非肽类有机化合物的内部文库进行了测定,并评估了它们对 FP-2 的活性及其抑制机制。(E)-查耳酮 48、54 和 66 显示出最低的 IC50 值(分别为 8.5±0.8 μM、9.5±0.2 μM 和 4.9±1.3 μM)。最好的抑制剂(化合物 66)表现出非竞争性抑制,并且通过质谱和荧光光谱测定法,我们提出了该化合物相互作用的潜在变构部位,位于 FP-2 的催化部位和血红蛋白结合臂之间。我们结合结构生物学工具和质谱法来表征针对 FP-2 的新型化合物的抑制机制。